Drugs Made in America Ac-RTSDMAARPreferred / convertible
13F holders, Q4 2025 (December 31)32holders
3new positions
2sold out
$0.18avg. 13F price*
At the end of Q4 2025, 32 institutions reported holding Drugs Made in America Ac-RTS (DMAAR) in their 13F filings, unchanged from Q3 2025. 3 opened new positions and 2 sold out. The largest holders were Polar Asset Management Partners Inc. ($356K), Hudson Bay Capital Management LP ($284K) and Harraden Circle Investments, LLC ($281K).
- Company
- Drugs Made in America Ac-RTS
- CUSIP
- G2847J112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $42K |
| Exits | 2 | $19K |
All 13F filers, Q3 2025 → Q4 2025: 391,792 shares bought and 377,590 shares sold, net +14,202 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Polar Asset Management Partners Inc. | — | No change | 1,900,000 | $356K |
| Hudson Bay Capital Management LP | — | No change | 1,800,000 | $284K |
| Harraden Circle Investments, LLC | — | No change | 1,500,000 | $281K |
| Toronto Dominion Bank | — | Add +0.3% | 1,003,000 | $188K |
| Aristeia Capital, L.L.C. | — | No change | 881,716 | $165K |
| Highbridge Capital Management LLC | — | Add +4.1% | 1,024,112 | $162K |
| Mangrove Partners Im, LLC | — | No change | 850,000 | $159K |
| Linden Advisors LP | — | No change | 850,000 | $148K |
| Clear Street Group Inc. | — | Reduce -5.1% | 625,435 | $117K |
| Shaolin Capital Management LLC | — | Add +4.3% | 600,000 | $112K |
| Boothbay Fund Management, LLC | — | No change | 570,000 | $107K |
| Wolverine Asset Management LLC | — | Reduce 0.0% | 563,136 | $105K |
| Glazer Capital, LLC | — | Reduce -8.8% | 536,852 | $101K |
| LMR Partners LLP | — | No change | 500,000 | $94K |
| Westchester Capital Management, LLC | — | No change | 500,000 | $79K |
| Rivernorth Capital Management, LLC | — | Add +31.4% | 417,998 | $78K |
| Whitebox Advisors LLC | — | No change | 400,000 | $75K |
| Alpine Global Management, LLC | — | No change | 362,500 | $68K |
| AQR Arbitrage LLC | — | Reduce -23.9% | 380,314 | $60K |
| Radcliffe Capital Management, L.P. | — | No change | 325,100 | $56K |
| CSS LLC | — | No change | 31,250 | $47K |
| Context Capital Management, LLC | — | No change | 250,000 | $47K |
| Heights Capital Management, Inc. | — | Reduce -19.1% | 234,109 | $37K |
| Bulldog Investors, LLP | — | No change | 130,264 | $24K |
| BNP Paribas Financial Markets | — | New | 119,686 | $22K |
| Schonfeld Strategic Advisors LLC | — | Reduce -20.1% | 117,480 | $22K |
| DLD Asset Management, LP | — | New | 101,594 | $19K |
| Quarry LP | — | No change | 100,000 | $19K |
| Verition Fund Management LLC | — | No change | 100,000 | $16K |
| Periscope Capital Inc. | — | No change | 75,000 | $14K |
| Readystate Asset Management LP | — | No change | 50,000 | $8K |
| Meteora Capital, LLC | — | New | 2,000 | $375 |
"% of holder's portfolio" is DMAAR's weight in each manager's 13F, not the share of Drugs Made in America Ac-RTS the manager owns.